These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
339 related items for PubMed ID: 25655628
21. Cerenkov Luminescence Imaging (CLI) for cancer therapy monitoring. Xu Y, Liu H, Chang E, Jiang H, Cheng Z. J Vis Exp; 2012 Nov 13; (69):e4341. PubMed ID: 23183774 [Abstract] [Full Text] [Related]
23. A Monte Carlo study of pinhole collimated Cerenkov luminescence imaging integrated with radionuclide treatment. Geng C, Ai Y, Tang X, Shu D, Gong C, Guan F. Australas Phys Eng Sci Med; 2019 Jun 13; 42(2):481-487. PubMed ID: 30830649 [Abstract] [Full Text] [Related]
26. Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re. Brouwers AH, van Eerd JE, Frielink C, Oosterwijk E, Oyen WJ, Corstens FH, Boerman OC. J Nucl Med; 2004 Feb 13; 45(2):327-37. PubMed ID: 14960657 [Abstract] [Full Text] [Related]
27. Radioimmunotherapy of prostate cancer targeting human kallikrein-related peptidase 2. Vilhelmsson Timmermand O, Larsson E, Ulmert D, Tran TA, Strand S. EJNMMI Res; 2016 Dec 13; 6(1):27. PubMed ID: 26983637 [Abstract] [Full Text] [Related]
30. Intraoperative Assessment of Tumor Resection Margins in Breast-Conserving Surgery Using 18F-FDG Cerenkov Luminescence Imaging: A First-in-Human Feasibility Study. Grootendorst MR, Cariati M, Pinder SE, Kothari A, Douek M, Kovacs T, Hamed H, Pawa A, Nimmo F, Owen J, Ramalingam V, Sethi S, Mistry S, Vyas K, Tuch DS, Britten A, Van Hemelrijck M, Cook GJ, Sibley-Allen C, Allen S, Purushotham A. J Nucl Med; 2017 Jun 13; 58(6):891-898. PubMed ID: 27932562 [Abstract] [Full Text] [Related]
32. Quantitative Measurement of the Thyroid Uptake Function of Mouse by Cerenkov Luminescence Imaging. Ke CC, He ZM, Hsieh YJ, Huang CW, Li JJ, Hwu L, Chen YA, Yang BH, Chang CW, Huang WS, Liu RS. Sci Rep; 2017 Jul 18; 7(1):5717. PubMed ID: 28720762 [Abstract] [Full Text] [Related]
33. In Vivo 3-Dimensional Radiopharmaceutical-Excited Fluorescence Tomography. Hu Z, Zhao M, Qu Y, Zhang X, Zhang M, Liu M, Guo H, Zhang Z, Wang J, Yang W, Tian J. J Nucl Med; 2017 Jan 18; 58(1):169-174. PubMed ID: 27660137 [Abstract] [Full Text] [Related]
34. Can 111In-RGD2 monitor response to therapy in head and neck tumor xenografts? Terry SY, Abiraj K, Lok J, Gerrits D, Franssen GM, Oyen WJ, Boerman OC. J Nucl Med; 2014 Nov 18; 55(11):1849-55. PubMed ID: 25349221 [Abstract] [Full Text] [Related]
36. A stylized computational model of the rat for organ dosimetry in support of preclinical evaluations of peptide receptor radionuclide therapy with (90)Y, (111)In, or (177)Lu. Konijnenberg MW, Bijster M, Krenning EP, De Jong M. J Nucl Med; 2004 Jul 18; 45(7):1260-9. PubMed ID: 15235075 [Abstract] [Full Text] [Related]
37. SPECT- and fluorescence image-guided surgery using a dual-labeled carcinoembryonic antigen-targeting antibody. Rijpkema M, Oyen WJ, Bos D, Franssen GM, Goldenberg DM, Boerman OC. J Nucl Med; 2014 Sep 18; 55(9):1519-24. PubMed ID: 24982436 [Abstract] [Full Text] [Related]